PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Non-phospho-STEP (Ser221) (D74H3) Rabbit Monoclonal Antibody
#5659 · $194
100
Citing papers
8.5k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Cell death mechanisms and regulation
15
Cancer-related Molecular Pathways
10
PI3K/AKT/mTOR signaling in cancer
9
Ubiquitin and proteasome pathways
8
Pancreatic and Hepatic Oncology Research
7
MicroRNA in disease regulation
5
Cancer Mechanisms and Therapy
5
Cytokine Signaling Pathways and Interactions
5
Papers citing this product
1
Increase in Endoplasmic Reticulum Stress–Related Proteins and Genes in Adipose Tissue of Obese, Insulin-Resistant Individuals
Diabetes
·
2008
·
461 cit.
·
DOI
2
Complexity of the microRNA repertoire revealed by next-generation sequencing
RNA
·
2010
·
281 cit.
·
DOI
3
Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
Journal of Experimental & Clinical Cancer Research
·
2018
·
230 cit.
·
DOI
4
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
Journal of Biological Chemistry
·
2004
·
212 cit.
·
DOI
5
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
Journal of Biological Chemistry
·
2010
·
190 cit.
·
DOI
6
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
International Journal of Cancer
·
2007
·
185 cit.
·
DOI
7
Acetylation of β-Catenin by CREB-binding Protein (CBP)
Journal of Biological Chemistry
·
2002
·
182 cit.
·
DOI
8
Regulation of T cell receptor signaling by activation-induced zinc influx
The Journal of Experimental Medicine
·
2011
·
170 cit.
·
DOI
9
Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway
Theranostics
·
2018
·
149 cit.
·
DOI
10
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
Science
·
2024
·
143 cit.
·
DOI
Show 90 more papers
Feedback